Article Text

Download PDFPDF
Review
Cystic fibrosis and the gut
  1. Mordechai Slae,
  2. Michael Wilschanski
  1. Paediatric Gastroenterology, Hadassah University Hospital, Jerusalem, Israel
  1. Correspondence to Professor Michael Wilschanski, Paediatric Gastroenterology, Hadassah University Hospital, Jerusalem POB 24035, Israel; michaelwil{at}hadassah.org.il

Abstract

Cystic fibrosis (CF) is a recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. The gene product, CFTR protein, has important manifestations in the intestine, pancreas and hepatobiliary system. Increased survival has caused CF to be primarily an adult disease today. Physicians must be knowledgeable as to the varied phenotype in the gastrointestinal tract. This review will outline the main gastrointestinal manifestations including a section on gastrointestinal malignancy in CF. Novel treatments treating the basic effect in CF are now being introduced and their effects on the gastrointestinal tract are discussed.

  • cystic fibrosis
  • pancreatic disease
  • cancer syndromes
  • chronic liver disease

Statistics from Altmetric.com

Footnotes

  • Contributors Following Professor Beatties kind invitation, my colleague MS and myself planned the main points of the article. MS researched new studies in pubmed. MS wrote the first draft after which we wrote the article together.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.